Amber Lifesciences Dapagliflozin + Metformin

Dapagliflozin and metformin are combined to treat type 2 diabetes. Dapagliflozin, an SGLT2 inhibitor, reduces glucose reabsorption in the kidneys. Metformin, a biguanide, decreases glucose production and improves insulin sensitivity. Together, they improve glycemic control, aid weight loss, and reduce blood pressure. Side effects may include urinary tract infections, hypoglycemia, and gastrointestinal disturbances. Regular monitoring of blood glucose and kidney function is advised.